News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Jonathan Zager: Melanoma session kicking off at SSO2025
Jonathan Zager/LinkedIn
Mar 29, 2025, 17:14

Jonathan Zager: Melanoma session kicking off at SSO2025

Jonathan Zager, Chief Academic Officer at Moffitt Cancer Center, shared a post on X:

“Melanoma session kicking off at SSO2025. Honored to be a moderator and thoroughly impressed with the quality of these amazing talks. Congrats to all the speakers.”

Jonathan Zager: Melanoma session kicking off at SSO2025

More posts featuring Jonathan Zager.

cancer Jonathan Zager Melanoma OncoDaily Oncology Society of Surgical Oncology SSO2025
Special Coverage
Blog
Mar 30, 2025, 18:26
Indiana’s first mobile lung screening program is officially on the road - IU Simon Comprehensive Cancer Center
Blog
Mar 30, 2025, 18:14
Join the Richard and Alice Bucher Emerald Circle and help create a world without pediatric cancers - St. Baldrick's Foundation
Blog
Mar 30, 2025, 18:01
Philippe Spiess: Always an honor to deliver an update in the management of bladder cancer with Tom Flaig
Blog
Mar 30, 2025, 17:46
Thought-provoking trial on localized pancreatic cancer presented by Ethan Agritelley at SSO2025 - Duke Surgical Oncology
Blog
Mar 30, 2025, 17:44
Addressing Gaps in Awareness, Care, and Support for the Early-Age Onset Digestive Cancer Community - European Cancer Organisation
Blog
Mar 30, 2025, 17:34
Olga Kantor: Fantastic presentation by Monika Masanam on MIBC after NST at SSO2025
Blog
Mar 30, 2025, 17:19
Carlos Ayala-Navarro on the immune microenvironment in appendiceal cancers - Moffitt Cancer Center
Blog
Mar 30, 2025, 17:19
Roupen Odabashian: Comparing Research Compensation - Healthcare vs AI
Blog
Mar 30, 2025, 17:05
Julien Mazieres: Heterogeneity of resistance mechanisms should lead to a personalized strategy
Blog
Mar 30, 2025, 16:56
Joe Chang: Optimal first-line treatment for EGFR-mutated mNSCLC
Positive
Mar 30, 2025, 16:44
Yüksel Ürün: FDA approves neoadjuvant and adjuvant durvalumab in MIBC
Blog
Mar 30, 2025, 16:43
Highlights from SSO25